Author

M. A. Dane

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

L. M. Heiser· 2 shared S. M. Gross· 2 shared A. S. Meyer· 1 shared C. Sanchez-Aguila· 1 shared E. Bucher· 1 shared F. Mohammadi· 1 shared P. J. Zhan· 1 shared T. A. Liby· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

L. M. Heiser

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Analysis and modeling of cancer drug responses using cell cycle phase-specific rate effects

S. M. Gross, F. Mohammadi, C. Sanchez-Aguila, P. J. Zhan, T. A. Liby, M. A. Dane, A. S. Meyer, L. M. Heiser

This study develops a computational model to analyze drug effects on cell cycle phases in breast cancer cells and identifies effective drug combinations.

bioRxiv · Jul 24, 2020Cancer Biology

High resolution AKT signaling in individual cells

S. M. Gross, M. A. Dane, E. Bucher, L. M. Heiser

This study develops a sensor to assess AKT signaling fidelity in individual cells and finds cells can distinguish multiple IGF-I doses and pathway inhibition.

bioRxiv · Oct 28, 2018Cell Biology